Does the MBOAT7 rs641738 TT genotype increase liver fat and inflammation?

The MBOAT7 rs641738 TT genotype is a significant genetic risk factor for the development and progression of metabolic-associated fatty liver disease (MAFLD/MASLD), primarily through its impact on hepatic lipid remodeling. Research indicates that this variant leads to a downregulation of the MBOAT7 enzyme, which is crucial for maintaining the proper balance of phosphatidylinositol species in the liver.

Clinical evidence and effectiveness

The association between the rs641738 TT genotype and liver pathology is well-documented in large-scale clinical studies, particularly in adult populations of European descent.

• Liver fat accumulation: The TT genotype is robustly linked to increased hepatic fat content, as measured by MRI-PDFF or magnetic resonance spectroscopy. The effect size is typically around +0.03 standard deviations, making it a statistically significant, albeit modest, independent driver of steatosis.
• Inflammation and injury: Carriers of the homozygous TT variant exhibit higher levels of alanine aminotransferase (ALT), a key clinical marker of liver injury. Histological assessments consistently show more severe hepatic inflammation and an increased risk of progression to non-alcoholic steatohepatitis (NASH).
• Disease progression: Beyond simple fat accumulation, the TT genotype is associated with a higher risk of advanced fibrosis (OR 1.22 in some recessive models). However, the overall risk for MAFLD can vary; while strongly supported in many adult cohorts, some studies in pediatric or non-European populations have shown inconsistent results.

Mechanistic explanations

The rs641738 T allele functions by reducing the expression of the MBOAT7 protein in hepatocytes, which triggers a cascade of metabolic disruptions:

• Lipid remodeling: MBOAT7 is a membrane-bound O-acyltransferase that incorporates arachidonic acid into lysophosphatidylinositol (LPI) to form phosphatidylinositol (PI 38:4). The TT genotype leads to a depletion of these specific PI species and an accumulation of LPI.
• Lipotoxicity and stress: This biochemical shift disrupts lipid droplet dynamics and hepatic lipid trafficking, promoting the accumulation of triglycerides and cholesterol esters.
• Inflammatory signaling: The resulting lipid imbalance and impaired autophagic flux exacerbate cellular stress and promote pro-fibrotic and inflammatory transcriptional changes, driving the transition from simple fat accumulation to active liver inflammation.

Bottom line

The MBOAT7 rs641738 TT genotype is a validated genetic driver of increased liver fat and inflammation. While its impact on overall MAFLD risk can be influenced by ethnicity and age, it remains a critical marker for identifying individuals at higher risk for progressive liver injury and fibrosis due to impaired lipid remodeling.